Shares of Genflow Biosciences plc (LON:GENF – Get Free Report) were down 3.7% on Thursday . The stock traded as low as GBX 1.86 and last traded at GBX 1.95. 6,609,427 shares were traded during trading, an increase of 208% from the average session volume of 2,142,671 shares. The stock had previously closed at GBX 2.02.
Genflow Biosciences Stock Performance
The firm has a market cap of £11.50 million, a price-to-earnings ratio of -6.11 and a beta of 2.29. The business’s 50 day moving average price is GBX 2.01 and its 200-day moving average price is GBX 2.08.
About Genflow Biosciences
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
See Also
- Five stocks we like better than Genflow Biosciences
- Priced for a Pullback or More Gains? These 3 Stocks Are Testing the Limits
- These 3 Agentic AI Stocks Have More Than Hype Behind Their Growth Stories
- Not Just Banks: 3 Trading Stocks to Watch After the Fed Rate Hike
- MarketBeat Week in Review – 09/14 – 09/18
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
